Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Atlas Venture Fund VIII, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/08/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
01/31/2023 SC 13G/A Atlas Venture Fund VIII, L.P. reports a 14.8% stake in INTEGRAL AD SCIENCE HOLDING CORP.
01/31/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
11/10/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/10/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
05/12/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/07/2022 SC 13G Atlas Venture Fund VIII, L.P. reports a 14.8% stake in Integral ad science holding corp.
01/26/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
06/29/2021 3 Atlas Venture Fund VIII, L.P. (10% Owner) has filed a Form 3 on INTEGRAL AD SCIENCE HOLDING CORP.
02/02/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2020 SC 13G/A Atlas Venture Fund VIII, L.P. reports a 6.5% stake in TRANSLATE BIO, INC.
02/04/2020 SC 13G Atlas Venture Fund VIII, L.P. reports a 7.6% stake in BICYCLE THERAPEUTICS
02/08/2019 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
07/03/2018 4 Atlas Venture Fund VIII, L.P. (10% Owner) has filed a Form 4 on Translate Bio, Inc.
Txns: Converted 3,832,010 shares @ $0
Converted 12,925,244 preferred shares @ $0
Converted 5,838,230 preferred shares @ $0
Converted 2,525,253 preferred shares @ $0
06/27/2018 3 Atlas Venture Fund VIII, L.P. (10% Owner) has filed a Form 3 on Translate Bio, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy